Cytodyn Inc Net Income per Employee (CYDY), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Cytodyn inc   (CYDY)
 

Cytodyn Inc Net Income per Employee

CYDY's Quarterly Results, Trends, Rankings, Statistics
Cytodyn Inc recorded a cumulative net loss of $-57 million during 12 month ending in the first quarter 2026.
The Healthcare sector has seen employees of 391 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 4122, from total ranking in previous quarter at 4746.


What is Income per Employee Ratio?






CYDY Net Income per Employee (Aug 31 2026)
I. Quarter
(May 31 2026)
IV. Quarter
(Feb 28 2026)
III. Quarter
(Nov 30 2025)
II. Quarter
(Aug 31 2025)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -4,078,214 -3,049,929 -2,770,929 -2,775,786 -1,501,571
CYDY's Total Ranking # 4122 # 4746 # 4107 # 438 # 3767
Seq. Net Income Change - - - - -


CYDY Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 392
Healthcare Sector # 840
Overall Market # 4122

Net Income per Employee Statistics
High Average Low
$ 267,500 $ -4,422,187 $ -16,974,857
(May 31 2025)   (May 31 2022)







Companies with similar Income per Employee for 12 month ending Aug 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Aug 31 2026Number of Employees Aug 31 2026


Date modified: 2026-10-15T04:50:51+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.